GE HealthCare (GEHC) director Culp buys 80,805 shares in open market

Rhea-AI Filing Summary

GE HealthCare Technologies director H. Lawrence Culp Jr. reported an open-market purchase of 80,805 shares of common stock at a weighted average price of $61.8783 per share, with individual trades between $61.50 and $62.22. Following this transaction, he indirectly holds 151,207 shares through a holding company, 328,268 shares through family trusts, and 12,699 shares directly.

Insider Trade Summary

Net Buyer: 80,805 shares ($5,000,076)

Net Buy 3 txns

Insider CULP H LAWRENCE JR

Role null

Bought 80,805 shs ($5.00M)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.01 per share	80,805	$61.8783	$5.00M
holding	Common Stock, par value $0.01 per share	--	--	--
holding	Common Stock, par value $0.01 per share	--	--	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 151,207 shares (Indirect, By holding company); Common Stock, par value $0.01 per share — 12,699 shares (Direct, null)

Footnotes (1)

1. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Reflects the transfer by the reporting person of 37,091 shares of GE HealthCare common stock to a family trust on May 1, 2025.

Key Figures

Open-market purchase: 80,805 shares Weighted average price: $61.8783 per share Trade price range: $61.50–$62.22 per share +3 more

6 metrics

Open-market purchase 80,805 shares Common Stock bought on May 6, 2026

Weighted average price $61.8783 per share Price for 80,805 purchased shares

Trade price range $61.50–$62.22 per share Range of individual purchase transactions

Indirect holding company stake 151,207 shares Shares indirectly held through holding company after purchase

Family trust holdings 328,268 shares Indirect shares held by family trusts after reported events

Direct holdings 12,699 shares Shares held directly after reported transactions

Key Terms

open-market purchase, weighted average price, family trusts, indirect ownership

4 terms

open-market purchase financial

"Purchase in open market or private transaction"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported represents the weighted average price of shares purchased."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

family trusts financial

"nature_of_ownership: By family trusts"

indirect ownership financial

"ownership_type: indirect; nature_of_ownership: By holding company"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CULP H LAWRENCE JR

(Last) (First) (Middle)

500 WEST MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/06/2026		P		80,805	A	$61.8783(1)	151,207	I	By holding company
Common Stock, par value $0.01 per share								12,699(2)	D
Common Stock, par value $0.01 per share								328,268(2)	I	By family trusts

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

2. Reflects the transfer by the reporting person of 37,091 shares of GE HealthCare common stock to a family trust on May 1, 2025.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GE HealthCare (GEHC) disclose in this Form 4?

GE HealthCare reported an open-market purchase by director H. Lawrence Culp Jr. of 80,805 common shares. The shares were bought at a weighted average price of $61.8783, indicating a sizable personal investment in the company’s stock.

At what prices did H. Lawrence Culp Jr. buy GEHC shares?

The weighted average purchase price was $61.8783 per share for 80,805 shares. According to the filing, the individual trades occurred in multiple transactions at prices ranging from $61.50 to $62.22 per share, inclusive.

How many GEHC shares does H. Lawrence Culp Jr. hold after this transaction?

After the reported transaction, Culp holds several positions in GE HealthCare stock. He indirectly owns 151,207 shares through a holding company, 328,268 shares through family trusts, and holds 12,699 shares directly in his own name.

How is the new GEHC share purchase by H. Lawrence Culp Jr. held?

The 80,805 purchased GE HealthCare shares are held indirectly through a holding company. The filing classifies this position as indirect ownership, separate from additional indirect holdings in family trusts and his smaller direct ownership stake.

What does the Form 4 say about family trust holdings of GEHC shares?

The filing shows 328,268 GEHC shares held indirectly via family trusts associated with H. Lawrence Culp Jr. A footnote explains this reflects a transfer of 37,091 shares to a family trust on May 1, 2025, in addition to existing trust holdings.

Does the GEHC Form 4 mention how trade details can be obtained?

Yes. The Form 4 states full trade details are available upon request. It notes that GE HealthCare, any security holder, or SEC staff may request complete information on the number of shares purchased at each price within the reported $61.50–$62.22 range.